Hyperkinetic Movement Disorders

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-01-23
Clinical Trial Update: Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Tianasen (ASO-GNAO1) for GNAO1-related encephalopathy presenting with epilepsy and movement disorders; c…